Drug intelligence / Profile preview

colloidal oatmeal cream with biomimetic lipid combination and beta glucan

Development stage
Unknown
Lead developer
Mantecorp Skincare
Administration
Topical
01

Overview

Colloidal oatmeal cream with biomimetic lipid combination and beta glucan (marketed as Epidrat Atop) is a topical dermo-cosmetic formulation developed by Mantecorp Skincare (Hypera Pharma) for the management of atopic dermatitis (AD). The product combines 1% colloidal prebiotic oatmeal, which supports the skin microbiome and provides anti-inflammatory benefits, with a biomimetic lipid technology (including ceramides) to restore the skin's physical barrier. The addition of beta-glucan further enhances the cream's soothing and immunomodulatory properties. Clinical studies, including data presented at the AAD 2024 Annual Meeting, have demonstrated that the cream significantly improves clinical scores such as SCORAD and POEM, increases skin hydration, and reduces the relative abundance of *Staphylococcus aureus* on the skin of multi-ethnic patients with mild to moderate atopic dermatitis.

Brand names
Epidrat Atop
Other names
colloidal oatmeal + biomimetic lipids + beta-glucan cream

Beyond the preview

Go deeper on colloidal oatmeal cream with biomimetic lipid combination and beta glucan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on colloidal oatmeal cream with biomimetic lipid combination and beta glucan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call